The Highest Anti-B Antibody Titer of 8192 in a Patient Undergoing ABO-incompatible Living-donor Liver Transplantation: How to Achieve Donor-specific B-cell Tolerance?
Open Access
- 22 August 2025
- journal article
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (9) , e1859
Abstract
No abstract availableFunding Information
- None (None)
This publication has 17 references indexed in Scilit:
- Impact of IgG3 Subclass and C1q-Fixing Donor-Specific HLA Alloantibodies on Rejection and Survival in Liver TransplantationAmerican Journal of Transplantation, 2015
- Impact of Rituximab Desensitization on Blood-Type-Incompatible Adult Living Donor Liver Transplantation: A Japanese Multicenter StudyAmerican Journal of Transplantation, 2014
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and FunctionAmerican Journal of Transplantation, 2013
- De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant RecipientsAmerican Journal of Transplantation, 2013
- ABO-incompatible adult liver transplantation when the anti-ABO antibody titer is high.2009
- B-Cell Surface Marker Analysis for Improvement of Rituximab Prophylaxis in ABO-Incompatible Adult Living Donor Liver TransplantationLiver Transplantation, 2007
- Experiences and problems pre‐operative anti‐CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO‐incompatible living‐donor liver transplantationClinical Transplantation, 2007
- Therapeutic Plasma Exchange: Complications and ManagementAmerican Journal of Kidney Diseases, 1994
- Increased Bile Duct Complications in Liver Transplantation Across the ABO BarrierAnnals of Surgery, 1993
- Liver transplantation across ABO blood group barriersThe Lancet, 1990